Get the Stockscreener App
126.65
0.80%
1.01
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $126.65, with a volume of 4.50M.
It is up +0.80% in the last 24 hours and up +1.63% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$125.64
Open:
$126.665
24h Volume:
4.50M
Relative Volume:
0.87
Market Cap:
$55.81B
Revenue:
$9.47B
Net Income/Loss:
$2.67B
P/E Ratio:
21.03
EPS:
6.0218
Net Cash Flow:
$2.28B
1W Performance:
-0.60%
1M Performance:
+1.63%
6M Performance:
-16.92%
1Y Performance:
-23.21%
1-Day Range:
$125.65
$130.65
1-Week Range:
$118.94
$132.49
52-Week Range:
$115.25
$177.00
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS vs TAK, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Zoetis stock gains after Q4 earnings & revenues beat estimates - MSN
Can Zoetis Inc. sustain its profitabilityGap Down & Expert Approved Momentum Ideas - mfd.ru
Zoetis Inc. (NYSE:ZTS) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Yahoo Finance
Aberdeen Group plc Has $160.38 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
What Zoetis (ZTS)'s Upbeat 2026 Outlook and Dividend Signal Means For Shareholders - simplywall.st
Lyell Wealth Management LP Sells 19,845 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. (ZTS) Global Q4 and Full-Year 2025 Earnings: Revenue Beats $2.4B - Bayelsa Watch
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook - Finviz
Zoetis Inc (NYSE:ZTS) Provides Optimistic FY26 Outlook - FXDailyReport.Com
Zoetis Inc. (NYSE:ZTS) Q4 2025 Earnings Call Transcript - Insider Monkey
Leerink Partners Adjusts Price Target on Zoetis to $133 From $130, Maintains Market Perform Rating - marketscreener.com
Zoetis (ZTS) Receives Updated Price Target from B of A Securitie - GuruFocus
Bank of America Forecasts Strong Price Appreciation for Zoetis (NYSE:ZTS) Stock - MarketBeat
Assessing Zoetis: Insights From 5 Financial Analysts - Benzinga
Wealthfront Advisers LLC Purchases 13,097 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Q4 Earnings Call Highlights - Yahoo Finance
ING Groep NV Takes $4.58 Million Position in Zoetis Inc. $ZTS - MarketBeat
Will Zoetis Inc. outperform the market in YEARInsider Buying & Accurate Intraday Trading Signals - mfd.ru
Atria Investments Inc Trims Holdings in Zoetis Inc. $ZTS - MarketBeat
ZTS Stock Price, Forecast & Analysis | ZOETIS INC (NYSE:ZTS) - ChartMill
Jim Cramer on Zoetis (ZTS): “It Does Seem to Be Dead Money” - MSN
Decoding Zoetis Inc (ZTS): A Strategic SWOT Insight - GuruFocus
Zoetis Delivers Strong Q4 2025 Beat; Sets Sights on Long-Acting Growth in 2026 - AlphaStreet News
Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Y - GuruFocus
Zoetis Inc. SEC 10-K Report - TradingView
Zoetis Stock Is In The Doghouse Despite Its Quarterly Beat; Here's Why - Investor's Business Daily
Zoetis (ZTS) Projects Strong FY26 Revenue and Net Income Growth - GuruFocus
Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Year Growth Amid Competitive ... - Yahoo Finance
Zoetis (ZTS) Surpasses Revenue Expectations in Q4, Highlights Fu - GuruFocus
Zoetis forecasts strong 2026 profit, revenue on steady pet-medicine demand - marketscreener.com
Zoetis Q4 2025 Earnings Beat Expectations - Intellectia AI
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide - Benzinga
Zoetis (ZTS) Q4 2025 Earnings: Strong International Growth and S - GuruFocus
Zoetis (ZTS) Q4 2025 Earnings Call Transcript - The Globe and Mail
How Investors May Respond To Zoetis (ZTS) Strong 2025 Results And Confident 2026 Earnings Guidance - Yahoo Finance
Zoetis (ZTS) Shares Dip Despite Beating Q4 2025 Expectations - GuruFocus
Zoetis (ZTS) Exceeds Q4 Expectations with Strong Earnings - GuruFocus
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates - Finviz
Zoetis forecasts upbeat 2026; pet‑care market pressure drags shares - TradingView
Zoetis Q4 2025 slides: 6% annual growth achieved, 3-5% projected for 2026 By Investing.com - Investing.com India
Morgan Stanley reiterates Overweight rating on Zoetis stock at $160 By Investing.com - Investing.com Nigeria
Zoetis Q4 2025 slides: 6% annual growth achieved, 3-5% projected for 2026 - Investing.com
Zoetis slips as outlook shows growth headwinds (ZTS:NYSE) - Seeking Alpha
Zoetis Inc. (ZTS): Navigating Innovation and Safety in a Mature Animal Health Market - FinancialContent
Earnings call transcript: Zoetis beats Q4 2025 EPS forecast, stock dips - Investing.com
Fund Update: 113,803 ZOETIS (ZTS) shares added to South Dakota Investment Council portfolio - Quiver Quantitative
Jefferies reiterates Buy rating on Zoetis stock with $170 price target By Investing.com - Investing.com India
Jefferies reiterates Buy rating on Zoetis stock with $170 price target - Investing.com Nigeria
Morgan Stanley reiterates Overweight rating on Zoetis stock at $160 - Investing.com
Zoetis (ZTS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates - The Globe and Mail
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):